TC BIOPHARM (HOLDINGS) PLC
CIK 0001872812
Revenue (TTM)
£3.84M
FY Dec 2024
Net Income (TTM)
−£15.3M
−159.0% YoY
FY Dec 2024
EPS Diluted (TTM)
−£0.03
+96.9% YoY
FY Dec 2024
Gross Margin
—
FY Dec 2024
Operating Margin
-332.1%
FY Dec 2024
Net Margin
-398.0%
FY Dec 2024
Free Cash Flow (TTM)
−£15.86M
FY Dec 2024
Cash
£1.5M
FY Dec 2024
Total Debt
—
FY Dec 2024
Shares Outstanding
1.99B sh
FY Dec 2024
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.